Why Globus Medical, Inc. (GMED) stock fell 12.8% on Friday, November 6, 2026
Globus Medical, Inc. (GMED) closed at $71.05, down 12.76% on Friday, November 6, 2026, on volume of 9,269,519 shares (6.3× its 3-month average); market value about $9.50B.
What happened: primary sources
Events Nexqual found for GMED on Friday, November 6, 2026 or the trading day before (November 5, 2026):
- Nov 5, 2026: Reported Q3 2026 results: adjusted EPS $1.23 vs consensus $1.20 (beat), revenue $763.7M vs consensus $792.5M (miss). Guidance: Full-year 2026 revenue guidance updated to $3.09 billion with non-GAAP fully diluted EPS guidance reaffirmed at $4.95 to $5.05. source
- Nov 5, 2026: SEC 8-K: Other material event source
Quoted from the filing: “On November 2, 2026, (the "Repurchase Program Increase Date"), the Company's Board of Directors authorized the Company to repurchase an additional $500.0 million of its Class A common stock under its existing share repurchase program (the "Repurchase Program Increase"). Following the Repurchase Program Increase, approximately $611.0 million remained available for future share repurchases under the Company's repurchase program as of the Repurchase Program Increase Date. The timing and actual number of shares…” - Nov 6, 2026: Canaccord Genuity: Target lowered, Buy, price target $115 → $105
- Nov 6, 2026: Wells Fargo: Target raised, Overweight, price target $99 → $100
- Nov 6, 2026: Needham: Target lowered, Buy, price target $117 → $100
- Nov 6, 2026: BMO Capital: Downgrade, Outperform → Market Perform, price target $94 → $78
- Nov 4, 2026: Form 4: Rhoads Ann D (Director) sold 5,000 shares ($425,000) under a Rule 10b5-1 plan source
- Nov 6, 2026: One of 5 Medical Devices stocks among the day's biggest losers (IRTC, AORT, QDEL, GMED, OFIX), with no comparable group among the biggest gainers
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on GMED
GMED stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: GMED results, November 5, 2026. Other big moves that day: November 6, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:32 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:32 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt